Acute necrotizing inflammatory disease after intracerebral injection of LCM virus is largely dependent on the host immune response to the virus and is controlled, in part, by a dominant gene which is closely linked to the H-2 locus. The F1 hybrid (H-2q/k) from mating a susceptible SWR/J mouse (H-2q/q) to a resistant C3H/HeJ mouse (H-2k/k) is susceptible to LCM virus disease. When such hybrids (H-2q/k) are backcrossed to susceptible parents (H-2q/q), all F2 offspring (H-2q/q, H-2q/k) are highly susceptible. In contrast, hybrid (H-2q/k) backcross to resistant parents (H-2k/k) results in half of the F2 offspring being susceptible (H-2q/k) while the other half are resistant (H-2k/k). Similarly, in congenic H-2q/q and H-2k/k mice, H-2q/q mice are relatively susceptible to acute LCM disease, whereas H-2k/k are resistant.
Article|
May 01 1973
HISTOCOMPATIBILITY-LINKED GENETIC CONTROL OF DISEASE SUSCEPTIBILITY : MURINE LYMPHOCYTIC CHORIOMENINGITIS VIRUS INJECTION
Michael B. A. Oldstone,
Michael B. A. Oldstone
From the Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037, and the Division of Immunology, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305
Search for other works by this author on:
Frank J. Dixon,
Frank J. Dixon
From the Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037, and the Division of Immunology, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305
Search for other works by this author on:
Graham F. Mitchell,
Graham F. Mitchell
From the Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037, and the Division of Immunology, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305
Search for other works by this author on:
Hugh O. McDevitt
Hugh O. McDevitt
From the Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037, and the Division of Immunology, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305
Search for other works by this author on:
Michael B. A. Oldstone
From the Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037, and the Division of Immunology, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305
Frank J. Dixon
From the Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037, and the Division of Immunology, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305
Graham F. Mitchell
From the Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037, and the Division of Immunology, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305
Hugh O. McDevitt
From the Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037, and the Division of Immunology, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305
Received:
January 10 1973
Online Issn: 1540-9538
Print Issn: 0022-1007
Copyright © 1973 by The Rockefeller University Press
1973
J Exp Med (1973) 137 (5): 1201–1212.
Article history
Received:
January 10 1973
Citation
Michael B. A. Oldstone, Frank J. Dixon, Graham F. Mitchell, Hugh O. McDevitt; HISTOCOMPATIBILITY-LINKED GENETIC CONTROL OF DISEASE SUSCEPTIBILITY : MURINE LYMPHOCYTIC CHORIOMENINGITIS VIRUS INJECTION . J Exp Med 1 May 1973; 137 (5): 1201–1212. doi: https://doi.org/10.1084/jem.137.5.1201
Download citation file: